SCHEMBL19019171

SCHEMBL19019171

NCCCNCCCCNCCCNc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.65
ALDH1A1 P00352 1/20 0.65
CA12 O43570 2/20 0.50
F13A1 P00488 2/20 0.50
CA2 P00918 2/20 0.50
CYP1A2 P05177 2/20 0.50
ALOX15 P16050 2/20 0.50
CA4 P22748 2/20 0.50
CA6 P23280 2/20 0.50
CA5A P35218 2/20 0.50
THPO P40225 2/20 0.50
CA7 P43166 2/20 0.50
CA9 Q16790 2/20 0.50
CA14 Q9ULX7 2/20 0.50
CA5B Q9Y2D0 2/20 0.50
CASP2 P42575 2/20 0.50
MEN1 O00255 1/20 0.50
CYP2C19 P33261 1/20 0.50
RECQL P46063 1/20 0.50
KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1072934 0.90 MAPT (0.73) MAPTALDH1A1HDAC3HDAC1HDAC2
SCHEMBL8628601 0.88 ALDH1A1 (0.77) MAPTALDH1A1
Hydrochloric Acid SCHEMBL12477885 0.88 ALDH1A1 (0.70) MAPTALDH1A1CYP1A2CYP2C19HDAC3
SCHEMBL1493178 0.88 ALDH1A1 (0.70) MAPTALDH1A1HDAC3HDAC1HDAC2
SCHEMBL5139921 0.88 ALDH1A1 (0.85) MAPTALDH1A1
SCHEMBL21800026 0.86 ALDH1A1 (0.67) MAPTALDH1A1HDAC3HDAC1HDAC2
SCHEMBL21799912 0.86 ALDH1A1 (0.67) MAPTALDH1A1HDAC3HDAC1HDAC2
SCHEMBL1937279 0.86 ALDH1A1 (0.60) MAPTALDH1A1CA12CA2ALOX15
SCHEMBL21224348 0.86 ALDH1A1 (0.67) MAPTALDH1A1HDAC3HDAC1HDAC2
SCHEMBL21799841 0.86 ALDH1A1 (0.67) MAPTALDH1A1HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017105565-A2 COMPOSITIONS FOR THERAPEUTICS, TARGETED PET IMAGING AND METHODS OF THEIR USE MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2017-06-22 WO disclosed